Cardiovascular toxicity of illicit anabolic-androgenic steroid use
Long-term AAS use was associated with myocardial dysfunction and coronary atherosclerosis.
Observational; exposure self-selected.
Original source ↗Loading TrenasCycles…
TrenasCycles
Loading TrenasCycles…
Anabolic-androgenic steroid
boldenone undecylenate
Equipoise has a reputation for gradual muscle gains, rather than a sudden watery jump in weight. Increased appetite and endurance are reported, not dependable benefits proven in people. Its usual undecylenate ester stays in the body for a long time. Raised blood counts, blood pressure and worse cholesterol are important downsides, and veterinary or underground products add quality concerns.
Human evidence is largely observational, forensic or confounded by multi-drug AAS use. No robust controlled bodybuilding trials were identified.
Erythrocytosis, blood-pressure and lipid changes, acne, infertility/suppression and possible cardiovascular/renal injury.
CBC/hematocrit; blood pressure; HDL/LDL/triglycerides; kidney/liver markers; reproductive hormones.
Not approved for human use; veterinary status must not be framed as human medical legitimacy.
Other aliases: boldenone undecylenate · EQ · Boldenone · Equipoise · Boldenone/Equipoise
Long-term AAS use was associated with myocardial dysfunction and coronary atherosclerosis.
Observational; exposure self-selected.
Original source ↗Reported renal structural/functional differences.
Multi-drug exposure prevents boldenone-specific attribution.
Original source ↗Documents forensic exposure in a fatality investigation.
Cannot establish causation or incidence.
Original source ↗